on July 8, 2026 at 3:44 am AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing DealJason ChauBy aumnamaah@gmail.com / July 8, 2026 Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
